| Literature DB >> 29264162 |
Akio Takayanagi1,2, Atsushi Takahashi1, Fumimasa Fukuta1,2, Manabu Okada1,2, Masahiro Matsuki1,2, Shunsuke Sato1,2, Teruhisa Uehara1,2, Shuichi Kato1,2, Yoshio Takagi1.
Abstract
OBJECTIVE: We evaluated who would need further evaluations such as retrograde pyelography (RP) and/or ureteroscopy to diagnose upper urinary tract urothelial cancers (UUTUCs) when abnormal findings for the upper urinary tract (UUT) were detected by enhanced computed tomography (CT).Entities:
Keywords: Enhanced CT; Retrograde pyelography; Upper urinary tract urothelial cancers; Ureteroscopy
Year: 2015 PMID: 29264162 PMCID: PMC5730801 DOI: 10.1016/j.ajur.2015.11.005
Source DB: PubMed Journal: Asian J Urol ISSN: 2214-3882
Patients' characteristics.
| Variable | Value |
|---|---|
| Number of patients, | 125 |
| Age, median (range) | 70 (36–86) |
| Reasons for CT, | |
| Hematuria | 39 (31.2) |
| Gross hematuria | 33 (26.4) |
| Microscopic hematuria | 6 (4.8) |
| Back pain | 15 (12.0) |
| Follow-up of bladder cancer | 11 (8.8) |
| Decrease of renal function | 5 (4.0) |
| Uncertain | 55 (44.0) |
| CT findings, | |
| With tumor-like lesion | 58 (46.4) |
| Without tumor-like lesion | 67 (53.6) |
| Urine cytology before UUTUC evaluation, | |
| Positive | 17 (13.6) |
| Controversial | 7 (5.6) |
| Negative | 83 (66.4) |
| Not performed | 18 (14.4) |
| Methods of UUTUC evaluation, | |
| RP only | 66 (52.8) |
| Ureteroscopy and RP | 55 (44.0) |
| Ureteroscopy only | 4 (3.2) |
CT, computed tomography; UUTUC, upper urinary tract urothelial cancer; RP, retrograde pyelography.
Figure 1The relationship between the CT findings and the final diagnosis. UUTUC, upper urinary tract urothelial cancer.
Univariate and multivariate analyses for risk factors to predict UUTUC in 58 patients.
| Risk factors | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | HR | 95% CI | |||
| Tumor diameter | 1.20 | 1.03–1.39 | 0.02 | 1.23 | 1.05–1.44 | 0.01 |
| Tumor enhancement | 7.05 | 1.86–26.69 | 0.004 | 6.78 | 1.33–34.45 | 0.02 |
| Hydronephrosis | 1.72 | 0.50–5.89 | 0.39 | 0.79 | 0.15–4.11 | 0.78 |
| Renal pelvic cancer | 1.07 | 0.31–3.72 | 0.91 | 0.25 | 0.04–1.43 | 0.12 |
UUTUC, upper urinary tract urothelial cancer; HR, hazard ratio; 95% CI, 95% confidence interval.
Figure 2ROC curve analysis to evaluate the diagnostic ability of enhanced CT. ROC, receiver operating characteristic; CT, computed tomography.
Diagnostic accuracy of RP and ureteroscopy for UUTUC in all 125 patients (%).
| RP ( | Ureteroscopy ( | |
|---|---|---|
| Sensitivity | 90.0 (36/40) | 95.5 (21/22) |
| Specificity | 98.8 (80/81) | 100 (37/37) |
| PPV | 97.3 (36/37) | 100 (21/21) |
| NPV | 95.2 (80/84) | 97.4 (37/38) |
| Accuracy | 95.9 (116/121) | 98.3 (58/59) |
RP, retrograde pyelography; UUTUC, upper urinary tract urothelial cancer; PPV, positive predictive value; NPV, negative predictive value.
Diagnostic accuracy of RP and ureteroscopy for UUTUC in 58 patients who had tumor-like lesions revealed by CT (%).
| RP ( | Ureteroscopy ( | |
|---|---|---|
| Sensitivity | 91.1 (41/45) | 95.7 (22/23) |
| Specificity | 100 (10/10) | 100 (11/11) |
| PPV | 100 (41/41) | 100 (22/22) |
| NPV | 71.4 (10/14) | 91.7 (11/12) |
| Accuracy | 92.7 (51/55) | 97.1 (33/34) |
RP, retrograde pyelography; UUTUC, upper urinary tract urothelial cancer; CT, computed tomography; PPV, positive predictive value; NPV, negative predictive value.
Figure 3The strategy to evaluate the UUT to detect UUTUC. UUT, upper urinary tract; CT, computed tomography; RP, retrograde pyelography; UUTUC, upper urinary tract urothelial cancer.